Tatva Chintan Pharma Chem consolidated net profit rises 116.23% in the September 2026 quarter

Sales rise 75.94% to Rs 217.32 crore

Net profit of Tatva Chintan Pharma Chem rose 116.23% to Rs 21.45 crore in the quarter ended September 2026 as against Rs 9.92 crore during the previous quarter ended September 2025. Sales rose 75.94% to Rs 217.32 crore in the quarter ended September 2026 as against Rs 123.52 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	217.32	123.52	76
OPM %	18.72	17.98	-
PBDT	39.73	22.72	75
PBT	28.94	13.66	112
NP	21.45	9.92	116

Powered by Capital Market - Live News